I have been tracking Doximity ( DOCS ) since the IPO, and frankly, it has been a frustrating one. The company prints cash and dominates its niche but trades like a penny stock the moment sentiment shifts.I'm a fundamental investor who targets situations where the market has pushed a company’s valuation far out of line with its underlying economics. My professional background in corporate financial analysis has deeply shaped my investment perspective, leading me to focus intensely on cash flow durability, ba ...